• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    (NY: HLN )

    8.455 -0.005 (-0.06%)
    Streaming Delayed Price Updated: 12:49 PM EDT, Jul 5, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,364,261
    Open 8.440
    Bid (Size) 8.450 (134)
    Ask (Size) 8.460 (139)
    Prev. Close 8.460
    Today's Range 8.405 - 8.490
    52wk Range 7.695 - 8.960
    Shares Outstanding N/A
    Dividend Yield 1.09%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Upcoming Stock Spinoffs: Should You Pounce or Pass?
    Stock spinoffs are a unique opportunity to pick up unloved, unwanted businesses but patience is often needed before buying in. 
    Via InvestorPlace
    Haleon To Offload Non-Core Nicotine Therapy Business To Dr. Reddy's For Over $600M
    Haleon has agreed to sell its nicotine replacement therapy business outside the U.S. to Dr. Reddy's Laboratories SA for £500 million ($632 million). This strategic move allows Haleon to focus on growth... 
    Via Benzinga

    Performance

    YTD
    +2.73%
    +2.73%
    1 Month
    +0.89%
    +0.89%
    3 Month
    +2.73%
    +2.73%
    6 Month
    +0.89%
    +0.89%
    1 Year
    +2.86%
    +2.86%

    More News

    Read More
    Sanofi Looks To Sell $20B Icy Hot Division: Likely Bidders Include Advent, PAI Partners, Blackstone, CVC
    Via Benzinga
    GSK Completely Exits Sensodyne Toothpaste Maker Haleon In $1.6B Sale
    Via Benzinga
    Pfizer To Cut Stake In Sensodyne Toothpaste-Maker Haleon, Potentially Worth £2B
    Via Benzinga
    Current Analysis: Haleon
    Via Talk Markets
    Earnings Scheduled For February 29, 2024
    Via Benzinga
    Haleon Earnings Preview
    Via Benzinga
    Dr. Reddy’s to Acquire Nicotinell and Related Portfolio in Significant Step Towards Building Global Consumer Healthcare Business
    From Dr. Reddy’s Laboratories Ltd.
    Via Business Wire
    Advil Maker Haleon Expects Higher 2024 Revenue After Strong 2023 Earnings, Stock Soars
    Via Benzinga
    Robitussin Recall 2024: What to Know About the New Cough Syrup Recalls
    Via InvestorPlace
    Peering Into Haleon's Recent Short Interest
    Via Benzinga
    How Is The Market Feeling About Haleon?
    Via Benzinga
    Looking Into Haleon's Recent Short Interest
    Via Benzinga
    Robitussin Recall: Here Are The Products Impacted And What You Need To Know
    Via Benzinga
    GSK Cuts More Stake In Its Spun-Off Consumer-Healthcare Business Haleon, Raises Over £900M
    Via Benzinga
    3 cheap 'stock'-ing stuffers Wall Street is bullish on
    Via MarketBeat
    Topics Stocks
    Exposures US Equities
    Health exclusion affects more than three in five people globally
    From Haleon
    Via GlobeNewswire
    How Is The Market Feeling About Haleon?
    Via Benzinga
    A Look Into Haleon Inc's Price Over Earnings
    Via Benzinga
    How Is The Market Feeling About Haleon?
    Via Benzinga
    Major Buyout Firms Eye Sanofi's Consumer Health Division Spinoff Valued Over $20B
    Via Benzinga
    7 Healthcare Stocks to invest in for a Healthy Future
    Via InvestorPlace
    GSK: Pharma Giant Prioritizing Shareholder Dividends
    Via Talk Markets
    Regulatory Shadow Over Saudi Golf League LIV And PGA Tour Merger, Novo Nordisk's Weight Loss Drugs May Pose Serious Stomach Risks, Netflix's Local Content and Pricing Woes Undermine Growth in India: Today's Top Stories
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.